𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiviral therapy for hepatitis C in the setting of liver transplantation

✍ Scribed by Gregory T. Everson; Clark C. Kulig


Book ID
107558401
Publisher
Springer
Year
2006
Tongue
English
Weight
574 KB
Volume
9
Category
Article
ISSN
1092-8472

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Ribavirin therapy for hepatitis C infect
✍ E. J. Gane; C. J. Tibbs; J. K. Ramage; B. C. Portmann; R. Williams πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 419 KB

Hepatitis C infection following orthotopic liver transplantation may lead to progressive chronic graft dysfunction. In this study, seven liver transplant recipients with chronic allograft dysfunction due to hepatitis C infection (one acquired and six recurrent infections) were treated with oral riba

Management of hepatitis C virus infectio
✍ Hector Rodriguez-Luna; Hugo E. Vargas πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 1 views

Posttransplantation recurrence of hepatitis C virus infection is a universal phenomenon with a highly variable natural history. 2. Approximately 10% to 25% of hepatitis C virusinfected recipients of liver allografts will develop cirrhosis within 5 years' after transplantation. 3. The 1-year actuaria

Anemia in liver transplant recipients un
✍ Sammy Saab; Mina K. Oh; Ayman B. Ibrahim; Francisco Durazo; Steven Han; Hasan Ye πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 166 KB πŸ‘ 1 views

Adherence to antiviral therapy is essential to achieve sustained virological responses in patients treated for hepatitis C. An important limitation to use of appropriate doses of ribavirin is development of anemia. The aim of this study is to identify risk factors associated with anemia in liver tra